EVALUATION OF NEUTRALIZING ANTIBODY RESPONSES AGAINST A LARGE RANGE OF WILD-TYPE ISOLATES IN SERA OF PRIMATES VACCINATED WITH A TETRAVALENT DENGUE VACCINE

被引：0
|
作者：
Barban, Veronique [1 ]
Girerd, Yves [1 ]
Arnaud-Barbe, Nadege [1 ]
Mantel, Nathalie [1 ]
Gulia, Sandrine [1 ]
Munoz-Jordan, Jorge L. [2 ]
Dumas, Rafaele [1 ]
机构：
[1] Sanofi Pasteur, Marcy Letoile, France
[2] Ctr Dis Control & Prevent, San Juan, PR USA
来源：
AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE | 2009年 / 81卷 / 05期
关键词：
D O I：
暂无
中图分类号：
R1 [预防医学、卫生学];
学科分类号：
1004 ; 120402 ;
摘要：
394
引用
收藏
页码：113 / 113
页数：1
相关论文
共 50 条
  • [21] The successful induction of T-cell and antibody responses by a recombinant measles virus-vectored tetravalent dengue vaccine provides partial protection against dengue-2 infection
    Hu, Hui-Mei
    Chen, Hsin-Wei
    Hsiao, Yu-Ju
    Wu, Szu-Hsien
    Chung, Han-Hsuan
    Hsieh, Chun-Hsiang
    Chong, Pele
    Leng, Chih-Hsiang
    Pan, Chien-Hsiung
    HUMAN VACCINES & IMMUNOTHERAPEUTICS, 2016, 12 (07) : 1678 - 1689
  • [22] Recombinant, live-attenuated tetravalent dengue virus vaccine formulations induce a balanced, broad, and protective neutralizing antibody response against each of the four serotypes in rhesus monkeys
    Blaney, JE
    Matro, JM
    Murphy, BR
    Whitehead, SS
    JOURNAL OF VIROLOGY, 2005, 79 (09) : 5516 - 5528
  • [23] Respiratory syncytial virus fusion nanoparticle vaccine immune responses target multiple neutralizing epitopes that contribute to protection against wild-type and palivizumab-resistant mutant virus challenge
    Gilbert, Brian E.
    Patel, Nita
    Lu, Hanxin
    Liu, Ye
    Guebre-Xabier, Mimi
    Piedra, Pedro A.
    Glenn, Gregory
    Ellingsworth, Larry
    Smith, Gale
    VACCINE, 2018, 36 (52) : 8069 - 8078
  • [24] Neutralizing antibodies and safety of a COVID-19 vaccine against SARS-CoV-2 wild-type and Omicron variants in solid cancer patients
    Chewaskulyong, Busyamas
    Satjaritanun, Pattarapong
    Ketpueak, Thanika
    Suksombooncharoen, Thatthan
    Charoentum, Chaiyut
    Nuchpong, Nuttaphoom
    Tantraworasin, Apichat
    PLOS ONE, 2024, 19 (11):
  • [25] A Third Dose of the COVID-19 Vaccine, CVnCoV, Increased the Neutralizing Activity against the SARS-CoV-2 Wild-Type and Delta Variant
    Wolz, Olaf-Oliver
    Kays, Sarah-Katharina
    Junker, Helga
    Koch, Sven D.
    Mann, Philipp
    Quintini, Gianluca
    Von Eisenhart-Rothe, Philipp
    Oostvogels, Lidia
    VACCINES, 2022, 10 (04)
  • [26] A bacterial extracellular vesicle-based intranasal vaccine against SARS-CoV-2 protects against disease and elicits neutralizing antibodies to wild-type and Delta variants
    Jiang, Linglei
    Driedonks, Tom A. P.
    Jong, Wouter S. P.
    Dhakal, Santosh
    van Saparoea, H. Bart van den Berg
    Sitaras, Ioannis
    Zhou, Ruifeng
    Caputo, Christopher
    Littlefield, Kirsten
    Lowman, Maggie
    Chen, Mengfei
    Lima, Gabriela
    Gololobova, Olesia
    Smith, Barbara
    Mahairaki, Vasiliki
    Richardson, M. Riley
    Mulka, Kathleen R.
    Lane, Andrew P.
    Klein, Sabra L.
    Pekosz, Andrew
    Brayton, Cory
    Mankowski, Joseph L.
    Luirink, Joen
    Villano, Jason S.
    Witwer, Kenneth W.
    JOURNAL OF EXTRACELLULAR VESICLES, 2022, 11 (03)
  • [27] SINGLE ADMINISTRATION OF LIVE-ATTENUATED TETRAVALENT DENGUE VACCINE CANDIDATE, KD-382, INDUCED LONG-LASTING (>3.5 YEARS) NEUTRALIZING ANTIBODY AGAINST ALL FOUR SEROTYPES IN DENGUE NAIVE CYNOMOLGUS MONKEYS
    Shinmura, Yasuhiko
    Yoshimura, Masaya
    Kameyama, Kazuhisa
    Sonoda, Kengo
    Yoksan, Sutee
    Kimachi, Kazuhiko
    AMERICAN JOURNAL OF TROPICAL MEDICINE AND HYGIENE, 2019, 101 : 246 - 246
  • [28] Vibriocidal antibody responses in North American volunteers exposed to wild-type or vaccine Vibrio cholerae O139: Specificity and relevance to immunity
    Losonsky, GA
    Lim, Y
    Motamedi, P
    Comstock, LE
    Johnson, JA
    Morris, JG
    Tacket, CO
    Kaper, JB
    Levine, MM
    CLINICAL AND DIAGNOSTIC LABORATORY IMMUNOLOGY, 1997, 4 (03) : 264 - 269
  • [29] Performance Evaluation of Three Antibody Binding Assays, a Neutralizing Antibody Assay, and an Interferon-Gamma Release Assay for SARS-CoV-2 According to Vaccine Type in Vaccinated Group
    Nam, Minjeong
    Cha, Jae Hyun
    Kim, Sang-Wook
    Kim, Sun Bean
    Lee, Ki-Byung
    Chung, You-Seung
    Yun, Seung Gyu
    Nam, Myung-Hyun
    Lee, Chang Kyu
    Cho, Yunjung
    DIAGNOSTICS, 2023, 13 (24)
  • [30] The kinetics of IgG subclasses and contributions to neutralizing activity against SARS-CoV-2 wild-type strain and variants in healthy adults immunized with inactivated vaccine
    Chen, Weixin
    Zhang, Lichi
    Li, Juan
    Bai, Shuang
    Wang, Yali
    Zhang, Bing
    Zheng, Qun
    Chen, Meng
    Zhao, Wei
    Wu, Jiang
    IMMUNOLOGY, 2022, 167 (02) : 221 - 232
12345